With $200M in hand, Cambridge startup sets goal: no blockbuster drugs

//With $200M in hand, Cambridge startup sets goal: no blockbuster drugs

With $200M in hand, Cambridge startup sets goal: no blockbuster drugs

Armed with one of the largest-ever Series A rounds, a new Cambridge startup is looking to upend the drug industry’s approach to pricing by creating competitor treatments that are “radically” cheaper.

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2020-01-12T16:01:31+00:00 January 12th, 2020|Healthcare|

About the Author: